Fujifilm Holdings (TSE:4901) company Cellular Dynamics International said today it is launching Opsis Therapeutics, a new venture aiming to develop treatments for patient suffering from retinal diseases. The newly formed business aims to focus on retinal cell manufacturing and application of regenerative medicines for treating retinal diseases, the company said. CDI made the initial seed investment […]
Cellular Dynamics International Inc.
Cellular Dynamics reveals plans for $41 million funding round
Ending months of silence, Cellular Dynamics International Inc. is finally talking about its nearly $41 million funding round that it says makes it the player with the deepest pockets in the stem cell arena.